Roche Diagnostics Corporation recalls Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of albumin in human serum a…
- Recall date
- March 18, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1194-2019
- FDA classification
- Class II
- Brand / firm
- Roche Diagnostics Corporation
- Sold / distributed
- US Nationwide distribution in the states of: GA, IL, KY, MI, and TX.
Why it was recalled
The reagent lot is exhibiting calibration failures, QC imprecision, and elevated QC recovery due to elevated pH level causing higher absorbance values.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of albumin in human serum and plasma on Roche/Hitachi cobas c systems.
Get recall alerts
Free email alert whenever Roche Diagnostics Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Roche Diagnostics Corporation